New tool aims to personalize breast cancer screening for thousands of women
NCT ID NCT04996316
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a tool called MammoScreen, a simple questionnaire that helps identify women at average or increased risk for breast cancer. The goal is to see if using this tool in clinics leads to more appropriate screening referrals. About 1,141 women aged 40 to 74 who use MyChart and read English will take part. The study does not test a treatment but aims to improve how breast cancer risk is assessed and managed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States